0001127602-16-061886.txt : 20160906
0001127602-16-061886.hdr.sgml : 20160906
20160906144010
ACCESSION NUMBER: 0001127602-16-061886
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160901
FILED AS OF DATE: 20160906
DATE AS OF CHANGE: 20160906
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES INC
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MARTIN JOHN C
CENTRAL INDEX KEY: 0001190578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 161870620
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DRIVE
CITY: FOSTER CITY
STATE: X1
ZIP: 94404
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2016-09-01
0000882095
GILEAD SCIENCES INC
GILD
0001190578
MARTIN JOHN C
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
1
1
Executive Chairman
Common Stock
2016-08-05
5
J
0
E
731917
0
A
731917
I
By Trust
Common Stock
2016-08-05
5
G
0
E
731917
0
D
3287810
D
Common Stock
2016-08-30
5
G
0
E
156714
0
D
3131096
D
Common Stock
2016-09-01
4
M
0
100000
16.395
A
3231096
D
Common Stock
2016-09-01
4
S
0
95600
77.451
D
3135496
D
Common Stock
2016-09-01
4
S
0
4400
78.1926
D
3131096
D
Non-qualified Stock Option (Right to Buy)
16.395
2016-09-01
4
M
0
100000
0
D
2017-01-22
Common Stock
100000
300000
D
Shares gifted to family trust.
Shares gifted to charitable trust
Sale prices reported for the transactions reported here range from $77.06 to $78.03. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Sale prices reported for the transactions reported here range from $78.07 to $78.36. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
/s/ Marissa Song by Power of Attorney for John C. Martin
2016-09-06